News - Headlands Research

About
Our Sites
CROs & Sponsors
Information Hub
- Blog
- Events
- In the Media
- News
- Resources
Careers
Contact

About
Our Sites
CROs & Sponsors
Information Hub
- Blog
- Events
- In the Media
- News
- Resources
Careers
Contact

News

May 25, 2022

TMP Press Release

May 25, 2022

Headlands Research’s Toronto Memory Program site and RetiSpec Awarded Grant to Launch Innovative Early Detection Program for Alzheimer’s

Read More

May 24, 2022

Headlands Research Brownsville

May 24, 2022

Groundbreaking Headlands Research and Pfizer Partnership to Significantly Improve Diversity in Clinical Trials

Read More

October 14, 2021

Milken Institute

October 14, 2021

Headlands Research CEO Mark Blumling to Speak at Milken Institute Global Conference

Read More

June 16, 2021

June 16, 2021

Multi-Site Contributor Headlands Research Congratulates Biogen on FDA Approval of Aducanumab for Alzheimer’s Disease

Read More

April 13, 2021

icons of medical equipment

April 13, 2021

Wall Street Journal: Covid-19 Vaccine: How Private-Equity Portfolio Companies Played a Role

Read More

December 21, 2020

Mark Blumling

December 21, 2020

ABC News: Vaccine Trackers: Bay Area Company Monitors Side Effects, Adverse Reactions For Future Safety

Read More

October 8, 2020

Vaccine from Russia

October 8, 2020

Wall Street Journal: COVID-19 Vaccine Trial Volunteers Look to Make A Difference

Read More

September 9, 2020

Dr. Joel Solis

September 9, 2020

NBC Nightly News: COVID-19 Devastates Latino Community Along The Southern Border

Read More

September 9, 2020

Mark Blumling

September 9, 2020

SF Business Times: Startup Looked To Change Vaccine, Drug Clinical Trials – Then Covid Changed It

Read More

September 2, 2020

Patient giving thumbs up while getting a shot

September 2, 2020

New York Post: Man Who Lost 7 Relatives To COVID-19 First To Try Experimental Vaccine In US

Read More

Posts pagination

← 1 2 3 4 5 →

130 John F Kennedy Dr STE 203 Lake Worth, FL 33462

© 2024 Headlands Research. | Privacy Policy

Facebook
LinkedIn
Twitter